PHI on the alliance for cell-based biomanufacturing
Phase Holographic Imaging, PHI, recently created a US-based alliance for advancing cell-based biomanufacturing with Wake Forest Institute for Regenerative Medicine, BioSpherix, QIAGEN and global...
Patient perspective in focus in Abliva’s phase II/III study
Biotech company Abliva is now preparing for the perhaps biggest step in the company's history to date – a pivotal phase II/III study with...
DanCann Pharma about the road to commercial breakthrough
DanCann Pharma is active within a growing field of drug development – medical cannabis and therapeutic cannabinoids. The goal is to provide patients in...
SynAct Pharma’s CSO comments approved IND and Q3
SynAct Pharma has received IND approval from the FDA, meaning that they can initiate the phase IIa/b RESOLVE study of AP1189 in DMARD-IR patients....
DanCann Pharma rides the cannabis legalisation wave
We are seeing a shift in the political will to decriminalise cannabis, not least in the US and Germany, where significant steps in legislature...
BioStock Investor Pitch: DanCann Pharma
Danish DanCann Pharma's goal is to improve the lives of patients through medical cannabis and cannabinoids. The company has signed an agreement with WEECO...
ClearPoint Neuro delivers first order to CLS
Following the FDA clearance of Clinical Laserthermia Systems’ MR-guided laser ablation system in neurosurgery, US commercialisation was swiftly initiated. The commercialisation is led by...
NLSDays: Sound Bioventures and Eir Ventures on the investment climate
One of NLSDays’ main aims is to connect investors and life science companies. Thus, several venture capital funds were present during the event in...
BioStock Studio: CLS about the FDA clearance
In December last year, medtech Clinical Laserthermia Systems applied for FDA clearance for the second generation of the TRANBERG Thermal Therapy System with Thermoguide...
BioStock Investor Meeting: Interview with OssDsign
In connection with the BioStock Investor Meeting in Stockholm, BioStock's reporter was visited by Anders Svensson, CFO of OssDsign. Svensson told us more about...
